ARCHIVES

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

Brawley: CMS Got it Right in Lung Cancer Screening Decision

November 14, 2014

NIH News: Board of Governors Appointed to Oversee Clinical Center

October 24, 1996

NCI To Fund 29% Of Grants In 1990, With Budget Cuts

February 17, 1989

In Brief: Jefferson Cancer Center Received $10 Million donation, Renamed Kimmel Cancer Center

March 29, 1996

Two Phase III Afatinib Trials Demonstrate Prolonged Survival

May 30, 2014

AACR Changes Its Logo— For The Fifth Time Since 2000

June 11, 2014